From the San Francisco Business Times. Shruthi Narayan has blood clots on the brain — in a good way. In fact, because of Narayan and the broader team at Penumbra, the Alameda company she leads has ...

Boston Scientific Corp. agreed to buy medical device maker Penumbra Inc. in a deal valued at more than $14 billion to expand in the treatment of blood clots and stroke. Boston Scientific said it will ...

Penumbra, Inc. PEN recently announced the FDA’s clearance and the launch of Lightning Flash 2.0, the next generation computer assisted vacuum thrombectomy (CAVT) system to remove venous thrombus and ...

Companies aim to introduce Penumbra’s most advanced peripheral mechanical thrombectomy technology to Japan upon regulatory approval Lightning technology is designed for single session blood clot ...

Campaign is led by prominent medical societies to minimize discrepancies in treating blood clot conditions, such as in pulmonary embolism, where there are often delays in care (up to 26% of patients ...

BOSTON--(BUSINESS WIRE)--Penumbra, Inc. (NYSE:PEN), a global interventional therapies company, today announced U.S. commercial availability of its most advanced thrombectomy device, the ACE™68 ...

Penumbra, Inc. (NYSE:PEN) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. The company announced the completion of enrollment in STORM-PE clinical trial. The pivotal, ...

Elizabeth Simms was 27 and pregnant when she was struck with a life-threatening pulmonary embolism. Her fourth pregnancy had ...

Survey Conducted by the Get Out the Clot Campaign, an Initiative Focused on Identifying and Closing Gaps in Patient Care for Blood Clots ALAMEDA, Calif., Sept. 9, 2025 /PRNewswire/ -- The American ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min At Penumbra Inc. Shruthi Narayan ...